WISP3 suppresses insulin-like growth factor signaling in human chondrocytes

Molecular and Cellular Endocrinology

Volumn 279, Issue 1-2, 2007, Pages 1-8

  Cui, Rong Rong ^a   Huang, Jiao ^b   Yi, Lu ^a   Xie, Hui ^a   Zhou, Hou De ^a   Yuan, Ling Qing ^a   Wang, Min ^c   Peng, Yi Qun ^a   Luo, Xiang Hang ^a   Liao, Er Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CCN6; Chondrocytes; Collagen II; ERK; IGF IR; IRS 1; SEDT PA; WISP3

Indexed keywords

COLLAGEN TYPE 2; CONNECTIVE TISSUE GROWTH FACTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; WNT 1 INDUCIBLE SECRETED PROTEIN 3;

ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

CELL LINE; CHONDROCYTES; COLLAGEN; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MUTATION; RECEPTOR, IGF TYPE 1; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 35649008827     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.08.007     Document Type: Article

References (23)

1. Akiyama H., Lyons J.P., Mori-Akiyama Y., Yang X., Zhang R., Zhang Z., Deng J.M., Taketo M.M., Nakamura T., Behringer R.R., McCrea P.D., and de C.B. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 18 9 (2004) 1072-1087
2. Baserga R., Hongo A., Rubini M., Prisco M., and Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1332 3 (1997) F105-F126
3. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327 2 (1993) 125-130
4. Butler A.A., Yakar S., Gewolb I.H., Karas M., Okubo Y., and LeRoith D. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B: Biochem. Mol. Biol. 121 1 (1998) 19-26
5. Clemmons D.R., Busby W.H., Garmong A., Schultz D.R., Howell D.S., Altman R.D., and Karr R. Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis. Arthritis Rheum. 46 3 (2002) 694-703
6. Davis L., Chen Y., and Sen M. WISP-3 functions as a ligand and promotes superoxide dismutase activity. Biochem. Biophys. Res. Commun. 342 1 (2006) 259-265
7. Goldring M.B., Birkhead J.R., Suen L.F., Yamin R., Mizuno S., Glowacki J., Arbiser J.L., and Apperley J.F. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J. Clin. Invest. 94 6 (1994) 2307-2316
8. Hurvitz J.R., Suwairi W.M., Van H.W., El-Shanti H., Superti-Furga A., Roudier J., Holderbaum D., Pauli R.M., Herd J.K., Van H.E., Rezai-Delui H., Legius E., Le M.M., Al-Alami J., Bahabri S.A., and Warman M.L. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat. Genet. 23 1 (1999) 94-98
9. Kleer C.G., Zhang Y., Pan Q., Gallagher G., Wu M., Wu Z.F., and Merajver S.D. WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer. Breast Cancer Res. 6 1 (2004) R110-R115
10. Kleer C.G., Zhang Y., Pan Q., and Merajver S.D. WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. Neoplasia 6 2 (2004) 179-185
11. Kolettas E., Muir H.I., Barrett J.C., and Hardingham T.E. Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor. Rheumatology (Oxford) 40 10 (2001) 1146-1156
12. Lee P.D., Rosenfeld R.G., Hintz R.L., and Smith S.D. Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J. Clin. Endocrinol. Metab. 62 1 (1986) 28-35
13. Liao E.Y., Peng Y.Q., Zhou H.D., Mackie E.J., Li J., Hu P.A., Zhou S.H., Wen G.B., Zhai M.X., Luo X.H., Tan L.H., and Ni J.D. Gene symbol: WISP3. Disease: spondyloepiphyseal dysplasia tarda with progressive arthropathy. Hum. Genet. 115 2 (2004) pp. 169
14. Matsumoto T., Tsurumoto T., Goldring M.B., and Shindo H. Differential effects of IGF-binding proteins, IGFBP-3 and IGFBP-5, on IGF-I action and binding to cell membranes of immortalized human chondrocytes. J. Endocrinol. 166 1 (2000) 29-37
15. Peng Y.Q., Liao E.Y., Gu H.M., Wei Q.Y., Zhou H.D., Li J., Xie H., Zhai M.X., Tan L.H., Luo X.H., Wu X.P., Hu P.A., Ni J.D., Su X., Jiang Y., Dai R.C., Guo L.J., Yuan L.Q., Wang M., Wang P.F., Liu S.P., Yang Y., Wang C., Sui G.L., and Fang T.Y. Pathology and molecular pathogenesis of spondyloepiphyseal dysplasia tarda with progressive arthropathy caused by compound CCN6 heterogeneous gene mutations. Zhonghua Yi Xue Za Zhi 84 21 (2004) 1796-1803
16. Pennica D., Swanson T.A., Welsh J.W., Roy M.A., Lawrence D.A., Lee J., Brush J., Taneyhill L.A., Deuel B., Lew M., Watanabe C., Cohen R.L., Melhem M.F., Finley G.G., Quirke P., Goddard A.D., Hillan K.J., Gurney A.L., Botstein D., and Levine A.J. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. U.S.A. 95 25 (1998) 14717-14722
17. Perbal B. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol. Pathol. 54 2 (2001) 57-79
18. Schlechter N.L., Russell S.M., Spencer E.M., and Nicoll C.S. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc. Natl. Acad. Sci. U.S.A. 83 20 (1986) 7932-7934
19. Sen M., Cheng Y.H., Goldring M.B., Lotz M.K., and Carson D.A. WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes. Arthritis Rheum. 50 2 (2004) 488-497
20. Starkman B.J., Cravero J.D., Delcarlo M., and Loeser R.F. IGF-I stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI 3-kinase pathway but not ERK MAPK. Biochem. J. 389 Pt 3 (2005) 723-729
21. Tamamura Y., Otani T., Kanatani N., Koyama E., Kitagaki J., Komori T., Yamada Y., Costantini F., Wakisaka S., Pacifici M., Iwamoto M., and Enomoto-Iwamoto M. Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J. Biol. Chem. 280 19 (2005) 19185-19195
22. Wynne-Davies R., Hall C., and Ansell B.M. Spondylo-epiphysial dysplasia tarda with progressive arthropathy. A "new" disorder of autosomal recessive inheritance. J. Bone Joint Surg. Br. 64 4 (1982) 442-445
23. Zhou, H.D., Bu, Y.H., Peng, Y.Q., Xie, H., Wang, M., Yuan, L.Q., Jiang, Y., Li, D., Wei, Q.Y., He, Y.L., Xiao, T., Ni, J.D., Liao, E.Y., 2007. Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation. J. Mol. Med. May 5, 2007; [Epub ahead of print].